Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease

被引:1
|
作者
Bhaskar C.Das [1 ]
Somsankar Dasgupta [2 ]
Swapan K.Ray [3 ]
机构
[1] Department of Medicine, Icahn School of Medicine at Mount Sinai
[2] Department of Neuroscience and Regenerative Medicine, Institute of Molecular Medicine and Genetics, Augusta University
[3] Department of Pathology, Microbiology, and Immunology, University of South Carolina School of Medicine
基金
美国国家卫生研究院;
关键词
Alzheimer’s disease; amyloid plaques; neurofibrillary tangles; neuroinflammation; neurodegeneration; retinoids;
D O I
暂无
中图分类号
R749.16 [];
学科分类号
100203 ;
摘要
All retinoids, which can be natural and synthetic, are chemically related to vitamin A. Both natural and synthetic retinoids use specific nuclear receptors such as retinoic acid receptors and retinoid X receptors to activate specific signaling pathways in the cells. Retinoic acid signaling is extremely important in the central nervous system. Impairment of retinoic acid signaling pathways causes severe pathological processes in the central nervous system, especially in the adult brain. Retinoids have major roles in neural patterning, differentiation, axon outgrowth in normal development, and function of the brain. Impaired retinoic acid signaling results in neuroinflammation, oxidative stress, mitochondrial malfunction, and neurodegeneration leading to progressive Alzheimer’s disease, which is pathologically characterized by extra-neuronal accumulation of amyloid plaques(aggregated amyloid-beta) and intra-neurofibrillary tangles(hyperphosphorylated tau protein) in the temporal lobe of the brain. Alzheimer’s disease is the most common cause of dementia and loss of memory in old adults. Inactive cholinergic neurotransmission is responsible for cognitive deficits in Alzheimer’s disease patients. Deficiency or deprivation of retinoic acid in mice is associated with loss of spatial learning and memory. Retinoids inhibit expression of chemokines and neuroinflammatory cytokines in microglia and astrocytes, which are activated in Alzheimer’s disease. Stimulation of retinoic acid receptors and retinoid X receptors slows down accumulation of amyloids, reduces neurodegeneration, and thereby prevents pathogenesis of Alzheimer’s disease in mice. In this review, we described chemistry and biochemistry of some natural and synthetic retinoids and potentials of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer’s disease.
引用
收藏
页码:1880 / 1892
页数:13
相关论文
共 50 条
  • [41] Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease
    Srivastava, Shriyansh
    Rajopadhye, Rohan
    Dey, Mangaldeep
    Singh, Rakesh Kumar
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (04) : 243 - 247
  • [42] Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics
    Vaiserman, Alexander
    Koliada, Alexander
    Lushchak, Oleh
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 189
  • [43] Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease
    Goyal, Divya
    Ali, Syed Afroz
    Singh, Rakesh Kumar
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 106
  • [44] Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer’s disease
    Juliet M. Taylor
    Zachery Moore
    Myles R. Minter
    Peter J. Crack
    [J]. Journal of Neural Transmission, 2018, 125 : 797 - 807
  • [45] The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum
    Pan, Rui
    Luo, Shuyi
    Huang, Qing
    Li, Weiwei
    Cai, Tianshu
    Lai, Kelin
    Shi, Xiaolei
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) : 1115 - 1125
  • [46] New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention
    Li, Tiantian
    Lu, Li
    Pember, Eloise
    Li, Xinuo
    Zhang, Bocheng
    Zhu, Zheying
    [J]. CELLS, 2022, 11 (12)
  • [47] Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease
    Taylor, Juliet M.
    Moore, Zachery
    Minter, Myles R.
    Crack, Peter J.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (05) : 797 - 807
  • [48] Astrocytes in neurodegeneration: potential target for Alzheimer's disease treatment
    Steardo, L.
    [J]. FEBS JOURNAL, 2011, 278 : 50 - 50
  • [49] Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration
    Butterfield, DA
    Boyd-Kimball, D
    Castegna, A
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) : 1313 - 1327
  • [50] Carotenoids and Alzheimer's Disease: An insight into therapeutic role of retinoids in animal models
    Obulesu, M.
    Dowlathabad, Muralidhara Rao
    Bramhachari, P. V.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2011, 59 (05) : 535 - 541